Kripps L-Arginine
Natural health product licensed in Canada
- Licence holder
- Kripps Pharmacy Ltd.
- NPN or DIN-HM
- 80000029
- Status
- Inactive licence
- Licence date
- 15 July 2004
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- (M) non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| L-arginine | 500 milligramme | Not calculated |
Non-medicinal ingredients
phosphate de dicalcium, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 4 Capsule | 3 Tous les jours |
Uses authorised in Canada
Supports cardiovascular function.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care provider prior to use if you have human herpes virus, sickle cell anemia, or if you are taking antihypertensives, cyclosporine, estrogens, birth control medications, medroxyprogesterone, norethindrone, nitrates, potassium increasing drugs, sildenafil, xylitol, and/or aminophyllins. Discontinue use if you have gout, decreased platelet count or elevated blood-urea nitrogen, serum creatine, creatinine or delayed menses.
- Effets indésirables connus
Abdominal pain; bloating; diarrhea; gout; allergic reactions such as rash, swelling, redness, increased pulse, sweating, nausea, vomiting.
- Contre-indications
Do not use if pregnant or breastfeeding, or if you have asthma. Do not use if you have had a myocardial infarction (heart attack).
Source
Official Health Canada record, licence 80000029
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.